Radiation
thoracic radiation
thoracic radiation is a radiation therapy with 3 clinical trials. Historical success rate of 50.0%.
Total Trials
3
Max Phase
—
Type
RADIATION
Molecule
—
Success Metrics
Clinical Success Rate
50.0%
Based on 1 completed trials
Completion Rate
50%(1/2)
Active Trials
0(0%)
Results Posted
100%(1 trials)
Terminated
1(33%)
Phase Distribution
Ph phase_2
3
100%
Phase Distribution
0
Early Stage
3
Mid Stage
0
Late Stage
Phase Distribution3 total trials
Phase 2Efficacy & side effects
3(100.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
50.0%
1 of 2 finished
Non-Completion Rate
50.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(1)
Terminated(1)
Other(1)
Detailed Status
Terminated1
unknown1
Completed1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
50.0%
Most Advanced
Phase 2
Trials by Phase
Phase 23 (100.0%)
Trials by Status
terminated133%
unknown133%
completed133%
Recent Activity
0 active trials
Showing 3 of 3
terminatedphase_2
Neoadjuvant Immunoradiation for Resectable Non-Small Cell Lung Cancer
NCT03237377
completedphase_2
A Study of Comparing Huachansu Plus Thoracic RT Versus RT Alone For ESCC
NCT02647125
unknownphase_2
A Study of Pemetrexed Plus Carboplatin Combined With Radiation in Patients With Inoperable Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC) (RT0801)
NCT00886678
Clinical Trials (3)
Showing 3 of 3 trials
NCT03237377Phase 2
Neoadjuvant Immunoradiation for Resectable Non-Small Cell Lung Cancer
NCT02647125Phase 2
A Study of Comparing Huachansu Plus Thoracic RT Versus RT Alone For ESCC
NCT00886678Phase 2
A Study of Pemetrexed Plus Carboplatin Combined With Radiation in Patients With Inoperable Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC) (RT0801)
All 3 trials loaded
Drug Details
- Intervention Type
- RADIATION
- Total Trials
- 3